BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24655302)

  • 1. Abnormal vocal cord movement treated with botulinum toxin in patients with asthma resistant to optimised management.
    Baxter M; Uddin N; Raghav S; Leong P; Low K; Hamza K; Holmes PW; Hamilton G; Thyagarajan D; Lau K; Bardin PG
    Respirology; 2014 May; 19(4):531-7. PubMed ID: 24655302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder.
    deSilva B; Crenshaw D; Matrka L; Forrest LA
    Laryngoscope; 2019 Apr; 129(4):808-811. PubMed ID: 30548857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
    Pham Q; Campbell R; Mattioni J; Sataloff R
    J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal vocal cord function in difficult-to-treat asthma.
    Low K; Lau KK; Holmes P; Crossett M; Vallance N; Phyland D; Hamza K; Hamilton G; Bardin PG
    Am J Respir Crit Care Med; 2011 Jul; 184(1):50-6. PubMed ID: 21471099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngeal botoxification for severe asthma.
    Gibson P
    Respirology; 2014 May; 19(4):467-8. PubMed ID: 24689853
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal vocal cord movement in patients with and without airway obstruction and asthma symptoms.
    Low K; Ruane L; Uddin N; Finlay P; Lau KK; Hamza K; Holmes PW; Hamilton G; Bardin PG
    Clin Exp Allergy; 2017 Feb; 47(2):200-207. PubMed ID: 27664415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
    Cha W; Jang JY; Wang SG; Kang JH; Jo MG
    J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cricothyroid and thyroarytenoid muscle botulinum toxin injection on patients with dyspnea caused by bilateral recurrent laryngeal nerve paresis].
    Xu XL; Lai JM; Qiu T; Ma YL; Jiao YC; Zhuang PY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):375-380. PubMed ID: 29764020
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe vocal cord dysfunction resistant to all current therapeutic interventions.
    Goldstein R; Bright J; Jones SM; Niven RM
    Respir Med; 2007 Apr; 101(4):857-8. PubMed ID: 17029770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome.
    Scott BL; Jankovic J; Donovan DT
    Mov Disord; 1996 Jul; 11(4):431-3. PubMed ID: 8813224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vocal cord dyskinesia and/or asthma].
    Braun JJ; Delmas C; Charloux A; Schultz P; de Blay F
    Rev Mal Respir; 2018 Jan; 35(1):62-68. PubMed ID: 29397301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral vocal fold paralysis: an unusual treatment with botulinum toxin.
    Andrade Filho PA; Rosen CA
    J Voice; 2004 Jun; 18(2):254-5. PubMed ID: 15193660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vocal fold granuloma: successful treatment with botulinum toxin.
    Orloff LA; Goldman SN
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):410-3. PubMed ID: 10504597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gasping for a Diagnosis: Pediatric Vocal Cord Dysfunction.
    Wenzel M
    J Pediatr Health Care; 2019 Jan; 33(1):5-13. PubMed ID: 29657076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin injection in laryngeal dyspnea.
    Woisard V; Liu X; Bes MC; Simonetta-Moreau M
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel scoring system to distinguish vocal cord dysfunction from asthma.
    Traister RS; Fajt ML; Landsittel D; Petrov AA
    J Allergy Clin Immunol Pract; 2014; 2(1):65-9. PubMed ID: 24565771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin injections for new onset bilateral vocal fold motion impairment in adults.
    Ekbom DC; Garrett CG; Yung KC; Johnson FL; Billante CR; Zealear DL; Courey MS
    Laryngoscope; 2010 Apr; 120(4):758-63. PubMed ID: 20213793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic botulinum toxin injections for paradoxical vocal fold motion in a child with cerebral palsy: a case study.
    Cheng YS; Bhutta MF; Ramsden JD; Lennox P
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):570-1. PubMed ID: 24485974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.